Response to letter – Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists - Archive ouverte HAL Access content directly
Journal Articles European Journal of Cancer Year : 2017

Response to letter – Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists

Domains

Life Sciences [q-bio] Pharmaceutical sciences Life Sciences [q-bio] Cancer
Fichier principal
Vignette du fichier
Response to_Androgen deprivation therapy .pdf (178.74 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Muriel Cadieu  : Connect in order to contact the contributor

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01661110

Submitted on : Monday, December 11, 2017-4:57:19 PM

Last modification on : Saturday, March 11, 2023-3:59:02 AM

Download

Dates and versions

hal-01661110 , version 1 (11-12-2017)

Identifiers

Cite

Lucie-Marie Scailteux. Response to letter – Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists. European Journal of Cancer, 2017, 87, pp.204. ⟨10.1016/j.ejca.2017.06.042⟩. ⟨hal-01661110⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

UNIV-RENNES1 UR1-UFR-SVE EHESP USPC REPERES UNIV-RENNES UR1-BIO-SA
110 View
171 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More